{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:52:06Z","timestamp":1789761126124,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Catholic Medical Center Research Foundation","award":["B0001-00039"],"award-info":[{"award-number":["B0001-00039"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2019R1G1A1009158"],"award-info":[{"award-number":["NRF-2019R1G1A1009158"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Despite the widespread use of F-18 fluorodeoxyglucose positron emission tomography\/computed tomography (FDG PET\/CT) in the diagnosis and response assessment of patients with lymphoma, few studies have assessed its value in ocular adnexal lymphomas. The purpose of this study was to evaluate the role of FDG PET\/CT in staging of non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas (OAML). In addition, the diagnostic sensitivity of FDG PET\/CT was compared with magnetic resonance imaging (MRI). FDG PET\/CT of 123 consecutive patients with pathologically proven OAML between January 2009 and February 2016 were retrospectively reviewed. The patients with MALT lymphoma originating from conjunctiva were excluded. A total 50 patients with non-conjunctival origin OAML were assessed. Maximum standardized uptake value (SUVmax) and additional PET parameters were measured for all lesions. Sensitivity for primary tumor detection was compared with MRI.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Ten patients had bilateral OAML and total 60 OAML lesions were analyzed. MRI was missing in one patient. The tumor locations were as follows: eyelid, 9; lacrimal gland, 18; orbit, 33. Fifty lesions (83.3%) were FDG-avid tumors with mean \u00b1 SD SUVmax 4.8 \u00b1 2.4 (range 2.0~11.1). The mean SUVmax according to tumor location were as follows: eyelid, 3.7 \u00b1 1.1 (2.8~5.3); lacrimal gland, 3.6 \u00b1 1.4 (2.1~6.4); orbit, 5.7 \u00b1 2.6 (2.0~11.1). Mean SUVmax among the 3 locations were statistically different (<jats:italic>P<\/jats:italic> = 0.010). The sensitivity was calculated as 83.1% (49\/59) for FDG PET\/CT and 89.8% (53\/59) for MRI, which were statistically comparable (<jats:italic>P<\/jats:italic> = 0.219 by McNemar\u2019s test). Seven of 50 patients (14%) were upstaged by detection of extraocular lesions by FDG PET\/CT (1 kidney and lung, 1 tonsil, 4 cervical LNs, 1 sacral foramen).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>83.3% of the non-conjunctival origin OAML were FDG-avid tumors, with FDG PET\/CT showing comparable sensitivity to that of MRI. FDG PET\/CT detected unsuspected extraocular lymphoma involvement in 14% of the patients. FDG PET\/CT performed for staging of non-conjunctival origin OAML may thus guide therapeutic management.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13550-019-0562-1","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T15:00:34Z","timestamp":1576508434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of F-18 FDG PET\/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas"],"prefix":"10.1186","volume":"9","author":[{"name":"On behalf of Catholic University Lymphoma Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Lim","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hyun","family":"O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya Youngju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Eun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeongsin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Ock","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Woo","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Woo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"562_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood-2008-12-195453","volume":"114","author":"A Stefanovic","year":"2009","unstructured":"Stefanovic A, Lossos IS. Extranodal marginal zone lymphoma of the ocular adnexa. Blood. 2009;114:501\u201310.","journal-title":"Blood."},{"key":"562_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ajh.21963","volume":"86","author":"SE Lee","year":"2011","unstructured":"Lee SE, Paik JS, Cho WK, Choi BO, Lee SN, Jung SE, et al. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Am J Hematol. 2011;86:262\u20136.","journal-title":"Am J Hematol"},{"key":"562_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/ajh.10332","volume":"73","author":"EY Cho","year":"2003","unstructured":"Cho EY, Han JJ, Ree HJ, Ko YH, Kang YK, Ahn HS, et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol. 2003;73:87\u201396.","journal-title":"Am J Hematol"},{"key":"562_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3341\/kjo.2013.27.4.243","volume":"27","author":"WK Cho","year":"2013","unstructured":"Cho WK, Lee SE, Paik JS, Cho SG, Yang SW. Risk potentiality of frontline radiotherapy associated cataract in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma. Korean J Ophthalmol. 2013;27:243\u20138.","journal-title":"Korean J Ophthalmol"},{"key":"562_CR5","doi-asserted-by":"crossref","first-page":"68583","DOI":"10.18632\/oncotarget.19788","volume":"8","author":"SY Kim","year":"2017","unstructured":"Kim SY, Yang SW, Lee WS, Yang JW, Oh SY, Ahn HB, et al. Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study. Oncotarget. 2017;8:68583\u201390.","journal-title":"Oncotarget."},{"key":"562_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s13139-018-0543-8","volume":"52","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Lee R, Choi H, Paeng JC, Cheon GJ, Lee DS, et al. Application of Quantitative Indexes of FDG PET to Treatment Response Evaluation in Indolent Lymphoma. Nucl Med Mol Imaging. 2018;52:342\u20139.","journal-title":"Nucl Med Mol Imaging"},{"key":"562_CR7","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048\u201358.","journal-title":"J Clin Oncol"},{"key":"562_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2967\/jnumed.109.067892","volume":"51","author":"M Weiler-Sagie","year":"2010","unstructured":"Weiler-Sagie M, Bushelev O, Epelbaum R, Dann EJ, Haim N, Avivi I, et al. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med. 2010;51:25\u201330.","journal-title":"J Nucl Med"},{"key":"562_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/hon.2152","volume":"33","author":"G Treglia","year":"2015","unstructured":"Treglia G, Zucca E, Sadeghi R, Cavalli F, Giovanella L, Ceriani L. Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis. Hematol Oncol. 2015;33:113\u201324.","journal-title":"Hematol Oncol"},{"key":"562_CR10","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1080\/10428194.2017.1298754","volume":"58","author":"D Albano","year":"2017","unstructured":"Albano D, Bosio G, Giubbini R, Bertagna F. 18F-FDG PET\/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation. Leuk Lymphoma. 2017;58:2328\u201334.","journal-title":"Leuk Lymphoma"},{"key":"562_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00259-016-3518-y","volume":"44","author":"D Albano","year":"2017","unstructured":"Albano D, Bertoli M, Ferro P, Fallanca F, Gianolli L, Picchio M, et al. 18F-FDG PET\/CT in gastric MALT lymphoma: a bicentric experience. Eur J Nucl Med Mol Imaging. 2017;44:589\u201397.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"562_CR12","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00277-015-2339-6","volume":"94","author":"SK Jung","year":"2015","unstructured":"Jung SK, Paik JS, Jung SE, Park G, Choi BO, Oh JK, et al. Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML). Ann Hematol. 2015;94:1185\u201393.","journal-title":"Ann Hematol"},{"key":"562_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.2214\/AJR.07.2629","volume":"191","author":"O Maksimovic","year":"2008","unstructured":"Maksimovic O, Bethge WA, Pintoffl JP, Vogel M, Claussen CD, Bares R, et al. Marginal zone B-cell non-Hodgkin\u2019s lymphoma of mucosa-associated lymphoid tissue type: imaging findings. AJR Am J Roentgenol. 2008;191:921\u201330.","journal-title":"AJR Am J Roentgenol"},{"key":"562_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3904\/kjim.2015.138","volume":"33","author":"JH Kim","year":"2018","unstructured":"Kim JH, Jeon YW, Choi BO, Park G, Hong YK, Yang SW, et al. Intracranial relapse as a solitary mass of ocular adnexal lymphoma of the mucosa-associated lymphoid tissue type. Korean J Intern Med. 2018;33:224\u20137.","journal-title":"Korean J Intern Med"},{"key":"562_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/01676830.2015.1078368","volume":"34","author":"JF English","year":"2015","unstructured":"English JF, Sullivan TJ. The role of FDG-PET in the diagnosis and staging of ocular adnexal lymphoproliferative disease. Orbit. 2015;34:284\u201391.","journal-title":"Orbit."},{"key":"562_CR16","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1016\/j.ophtha.2006.05.059","volume":"113","author":"AA Valenzuela","year":"2006","unstructured":"Valenzuela AA, Allen C, Grimes D, Wong D, Sullivan TJ. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease. Ophthalmology. 2006;113:2331\u20137.","journal-title":"Ophthalmology."},{"key":"562_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3928\/15428877-20070701-08","volume":"38","author":"I Gayed","year":"2007","unstructured":"Gayed I, Eskandari MF, McLaughlin P, Pro B, Diba R, Esmaeli B. Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy. Ophthalmic Surg Lasers Imaging. 2007;38:319\u201325.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"562_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1179\/102453312X13221316477813","volume":"17","author":"M Zanni","year":"2012","unstructured":"Zanni M, Moulin-Romsee G, Servois V, Validire P, B\u00e9namor M, Plancher C, et al. Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience. Hematology. 2012;17:76\u201384.","journal-title":"Hematology."},{"issue":"17","key":"562_CR19","doi-asserted-by":"publisher","first-page":"e0543","DOI":"10.1097\/MD.0000000000010543","volume":"97","author":"Hayahiko Fujii","year":"2018","unstructured":"Fujii H, Tanaka H, Nomoto Y, Harata N, Oota S, Isogai J, et al. Usefulness of 18F-FDG PET\/CT for evaluating response of ocular adnexal lymphoma to treatment. Medicine (Baltimore). 2018;97:e0543.","journal-title":"Medicine"},{"key":"562_CR20","unstructured":"NCCN Clinical Practice Guidelines in oncology B-Cell Lymphomas Version 4.2018. 2018."},{"key":"562_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/IOP.0000000000000789","volume":"33","author":"BA Thuro","year":"2017","unstructured":"Thuro BA, Ning J, Peng SA, Pace ST, Dudeja G, Ozgur O, et al. Rates of positive findings on positron emission tomography and bone marrow biopsy in patients with ocular adnexal lymphoma. Ophthalmic Plast Reconstr Surg. 2017;33:355\u201360.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"562_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ajh.23730","volume":"89","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Am J Hematol. 2014;89:726\u201331.","journal-title":"Am J Hematol"},{"key":"562_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00002341-199905000-00006","volume":"15","author":"TE Johnson","year":"1999","unstructured":"Johnson TE, Tse DT, Byrne GE Jr, Restrepo A, Whitcomb CC, Voigt W, et al. Ocular-adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients. Ophthalmic Plast Reconstr Surg. 1999;15:171\u20139.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"562_CR24","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0360-3016(02)04159-7","volume":"55","author":"S Martinet","year":"2003","unstructured":"Martinet S, Ozsahin M, Belkac\u00e9mi Y, Landmann C, Poortmans P, Oehlere C, et al. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003;55:892\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hon.2578","volume":"37","author":"I Vaxman","year":"2019","unstructured":"Vaxman I, Bernstine H, Kleinstern G, Hendin N, Shimony S, Domachevsky L, et al. FDG PET\/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma. Hematol Oncol. 2019;37:168\u201375.","journal-title":"Hematol Oncol"},{"key":"562_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hon.2563","volume":"37","author":"D Albano","year":"2019","unstructured":"Albano D, Bosio G, Camoni L, Farina M, Re A, Tucci A, et al. Prognostic role of baseline (18) F-FDG PET\/CT parameters in MALT lymphoma. Hematol Oncol. 2019;37:39\u201346.","journal-title":"Hematol Oncol"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-019-0562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-019-0562-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-019-0562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T01:17:52Z","timestamp":1605835072000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-019-0562-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1186\/s13550-019-0562-1","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"12 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by our Institutional Review Board (KC19RESI0058). Informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}